| abstract |
The invention relates to a compound described by a general formula (1), wherein each X independently can be OPO3 2-, OPSO2 2- or OSO3 - ; R1 comprises a solubility function such as a polyethylene glycol moiety and each X independently can be OPO3 2-, OPSO2 2-, - or OSO3 -; and Z is an alkyl chain comprising 1 to 3 carbon and/or hetero atoms. The invention further relates to polysulfate derivatives or mixed polyphosphate/sulphate derivatives of six-membered cyclic polyols for use in the therapy of infection by Clostridium difficile. |